As many as a third of people with “wet” age-related macular degeneration, a blinding retinal disease, may someday be able to safely stop eye injection therapy without further vision loss, a preliminary study shows.
The findings fall short of setting a timeline for ending treatment or predicting precisely which patients can stop injections, the researchers say, but add to growing evidence that many people with the disease may not need the lifelong monthly medication currently recommended.
